e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diffuse parenchymal lung disease III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
18F-FDG (fluorodeoxyglucose) uptake in focal organizing pneumonia mimicking bronchial carcinoma
A. Baha, F. Yildirim, N. Kokturk, U. O. Akdemir, S. Demircan (Ankara, Turkey)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease III
Session:
Diffuse parenchymal lung disease III
Session type:
Thematic Poster Session
Number:
3802
Disease area:
Interstitial lung diseases, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Baha, F. Yildirim, N. Kokturk, U. O. Akdemir, S. Demircan (Ankara, Turkey). 18F-FDG (fluorodeoxyglucose) uptake in focal organizing pneumonia mimicking bronchial carcinoma. Eur Respir J 2013; 42: Suppl. 57, 3802
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Prognostic value of dual-time-point
18
F-FDG PET in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Source: Eur Respir J 2007; 29: 995-1002
Year: 2007
Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?
Source: Eur Respir J 2003; 21: 848-854
Year: 2003
Multi-detector row computed tomography in imaging of interstitial lung diseases
Source: Annual Congress 2013 –Functional imaging
Year: 2013
18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging in COPD
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
Fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDGPET) may be useful in the management of sarcoidosis
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Ultrasound in the assessment of interstitial lung diseases: Correlation with high-resolution computed tomography and lung functions
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Lung
18
F-FDG uptake correlates with lung function alteration in patients with IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Synoptical table of idiopathic interstital pneumonia (IIP) findings in computed tomography (CT) – A practical tool and systematic review
Source: International Congress 2014 – ILDs 5
Year: 2014
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study
Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020
Year: 2021
Density gradient of the lung parenchyma at computed tomography in patients with pulmonary hypertension
Source: International Congress 2014 – ILDs 3
Year: 2014
The role of
99m
Tc labelled depreotide scanning in investigating suspected lung cancer - more than just the solitary pulmonary nodule
Source: Eur Respir J 2002; 20: Suppl. 38, 458s
Year: 2002
MR imaging of lung parenchymal changes in sarcoidosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
PET-CT with
18
F-FDG and
18
F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
CT and interstitial lung disease
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018
18F-Fluorodeoxyglucose (18FDG) PET pulmonary imaging: Role in detecting vascular inflammation
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept